The European Union’s drug regulator on Thursday approved the use of the Pfizer-BioNtech coronavirus vaccine for children aged 5 to 11, as Europe grapples with a resurgence of COVID cases.
The recommendation of the European Medicines Agency will now be sent to the European Commission for final approval. The health officials of each country in the block will then start vaccinating children and when.
Looking for Black Friday deals?
Don’t miss a minute of the action with our live coverage of Black Friday 2021 deals.
While children have a lower risk of serious COVID-19 illness and death than the adult population, they can still transmit the disease to others. Children now account for the majority of cases in Germany and the Netherlands, and officials say vaccination is key to stopping the spread.
NS COVID-19 vaccines are highly effective On preventing hospitalization more deaths, and the US Federal Drug Administration has found that a vaccine formula, called Comirnati, for 5- to 11-year-olds contains a Efficacy rate of 90.7%,
“The benefits of Komirnati outweigh the risks in children 5 to 11 years of age, especially in conditions that increase the risk of severe COVID-19,” EMA said in a statement.
The approval came as Europe faced the fourth wave of the pandemic. More than 100,000 people have died in Germany since the start of the pandemic as a result of COVID-19, a public health agency said on Thursday. Neighboring Austria, which last week became the first European country to make COVID vaccination a legal requirement, returned to a full national lockdown on Monday, while the Netherlands has implemented a Partial lockdown of three weeks.
The information contained in this article is for educational and informational purposes only and is not intended to be health or medical advice. Always consult with a physician or other qualified health provider with respect to any questions you may have about a medical condition or health purposes.